ECMO Net Registry Risk Model Calculator
Calculate the ECMOnet Score
Enter the five variables used in the published model for patients considered for VV-ECMO.
Use this score only as an adjunct to clinical assessment; it must not determine ECMO candidacy or timing on its own.
The published 4.5 cutoff was identified for mortality-risk prediction in a small cohort with influenza A (H1N1)-associated ARDS. The score does not provide a calibrated individual survival percentage.
About the ECMOnet Score
The ECMOnet score was developed to stratify mortality risk at VV-ECMO initiation, emphasizing extrapulmonary organ function and pre-ECMO hospital course. The original prospective multicentre cohort included 60 patients with influenza A (H1N1)-associated ARDS.
Published scoring criteria
| Variable | Value | Points |
|---|---|---|
| Pre-ECMO hospital stay | ≤3 / 4–7 / 8–11 / >11 days | 0.5 / 1 / 1.5 / 2 |
| Total bilirubin (mg/dL) | ≤0.15 / 0.16–0.65 / 0.66–1.15 / 1.16–1.65 / 1.66–2.15 / >2.15 | 0 / 0.5 / 1 / 1.5 / 2 / 2.5 |
| Creatinine (mg/dL) | ≤0.50 / 0.51–0.80 / 0.81–1.10 / 1.11–1.40 / 1.41–1.70 / 1.71–2.00 / 2.01–2.30 / >2.30 | 0 / 0.5 / 1 / 1.5 / 2 / 2.5 / 3 / 3.5 |
| Hematocrit (%) | >40 / 36–40 / 31–35 / ≤30 | 0.5 / 1 / 1.5 / 2 |
| Mean arterial pressure (mmHg) | >90 / 61–90 / ≤60 | 0 / 0.5 / 1 |
Cutoff and limitations
A score of 4.5 was reported as the most appropriate cutoff for mortality-risk prediction in the original study. This is not a fixed mortality probability and should be interpreted in the context of the derivation population and local ECMO practice.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.